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Abstract
Objective: The relationship between serum testosterone (T) levels, muscle mass and muscle force in eugonadal men is
incompletely understood. As polymorphisms in the androgen receptor (AR) gene cause differences in androgen sensitivity,
no straightforward correlation can be observed between the interindividual variation in T levels and different phenotypes.
Therefore, we aim to investigate the relationship between genetic variations in the AR, circulating androgens and muscle
mass and function in young healthy male siblings.
Design: 677 men (25–45 years) were recruited in a cross-sectional, population-based sibling pair study.
Methods: Relations between genetic variation in the AR gene (CAGn, GGNn, SNPs), sex steroid levels (by LC-MS/MS), body
composition (by DXA), muscle cross-sectional area (CSA) (by pQCT), muscle force (isokinetic peak torque, grip strength) and
anthropometrics were studied using linear mixed-effect modelling.
Results: Muscle mass and force were highly heritable and related to age, physical activity, body composition and
anthropometrics. Total T (TT) and free T (FT) levels were positively related to muscle CSA, whereas estradiol (E2) and free E2
(FE2) concentrations were negatively associated with muscle force. Subjects with longer CAG repeat length had higher
circulating TT, FT, and higher E2 and FE2 concentrations. Weak associations with TT and FT were found for the rs5965433
and rs5919392 SNP in the AR, whereas no association between GGN repeat polymorphism and T concentrations were found.
Arm span and 2D:4D finger length ratio were inversely associated, whereas muscle mass and force were not associated with
the number of CAG repeats.
Conclusions: Age, physical activity, body composition, sex steroid levels and anthropometrics are determinants of muscle
mass and function in young men. Although the number of CAG repeats of the AR are related to sex steroid levels and
anthropometrics, we have no evidence that these variations in the AR gene also affect muscle mass or function.
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Introduction
Skeletal muscle mass and function are highly heritable [1] and
influenced by age, anthropometrics, sex steroid status and lifestyle-
related factors [2–4]. The clinical relationship between androgens
and muscle mass is well-described. Androgen deficiency (i.e.
hypogonadism) leads to significant muscle loss and weakness [5],
whereas testosterone (T) supplementation has dose-dependent
anabolic effects [6,7]. Moreover, impaired steroid production or
low androgen sensitivity could interfere with normal bone
development and closure of the epiphyseal growth plates at the
end of puberty.
However, the interrelationship between T levels, muscle mass
and muscle force in eugonadal men is less clear [8]. Serum T levels
are maintained at appropriate levels by the hypothalamic-
pituitary-gonadal feedback loop. In healthy men, a large
interindividual variation in serum T levels exists [9]. This
between-subjects variability in T levels has been related to
environmental conditions such as age, body mass index and
smoking [10], and is considerably influenced by genetic factors
[11,12]. The sensitivity to circulating T is determined in part by
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the transcriptional activity of the androgen receptor (AR).
Polymorphisms in the AR gene have been described to alter this
activity. We have previously shown that diminished androgen
feedback, and consequently higher serum T concentrations, are
associated with the CAG repeat length, and to a lesser extend with
the GGN repeat length [9,13]. Furthermore, some single
nucleotide polymorphisms (SNP) in the AR gene, resulting in an
altered binding with cofactors, have been linked with the androgen
insensitivity syndrome (AIS) [14–16] and could therefore affect
androgen action and circulating androgen levels.
In order to gain more insight into the between subject variation
in muscle mass in young healthy men, we investigated the
relationship between androgens and muscle mass and function, as
well as the influence of genetic components. We hypothesized that
genetic variations in the AR, causing differences in androgen
sensitivity, contribute to the variation in muscle mass in young
healthy men.
Materials and Methods
Ethics statement
The study protocol was conducted according to the Helsinki
Declaration and was approved by the ethical committee of the
Ghent University Hospital. All participants gave their written
informed consent and questionnaires about previous illness and
medication use were completed. Physical activity was scored using
the questionnaire as proposed by Baecke et al. [17].
Study design and population
This population-based cross-sectional study is part of a larger
study, from which inclusion criteria and study design were
described previously [18]. Participants were recruited from the
population registries of 3 semi-rural to suburban communities
around Ghent, Belgium. Men (n = 12446), 25–45 years of age
were contacted by direct mailing, briefly describing the study
purpose and asking if they had a brother within the same age
range also willing to participate (maximal age difference between
brothers was set at 12 yrs). The overall response rate was 30.2%.
Finally, a sample of 768 young healthy men who fulfilled the
primary inclusion criterion of having a brother within the same
age range agreed to participate. After exclusions, 677 men in total
were included in the study. Two hundred ninety six pairs of
brothers (for a total of 592 men) were included in addition to 64
men as single participants, when their brother could not
participate in the study; 19 men were included as third brother
in a family and 2 as fourth brother. Exclusion criteria were defined
as illnesses or medication use affecting body composition,
hormone levels or bone metabolism.
Body composition and muscle strength
Body weight and anthropometrics (arm span, hand and finger
length) were measured in light indoor clothing without shoes.
Sternum height was measured using a wall-mounted Harpenden
stadiometer (Holtain, Crymych, UK). Lean and fat mass of the
whole body were measured using dual-energy x-ray absorptiom-
etry (DXA) with a Hologic QDR-4500A device (software version
11.2.1; Hologic, Bedford, MA, USA). Isokinetic peak torque of
biceps and quadriceps muscles was assessed at the dominant limbs
using an isokinetic dynamometer (Biodex, New York, NY, USA).
Grip strength at the dominant hand was measured using an
adjustable hand-held standard grip device (JAMAR hand dyna-
mometer; Sammons & Preston, Bolingbrook, IL, USA). Their
maximum performance was assumed to best reflect the current
status and the history of their musculoskeletal adaptation.
Cross-sectional muscle area
A peripheral quantitative computed tomography (pQCT)
device (XCT-2000, software version 5.4; Stratec Medizintechnik,
Pforzheim, Germany) was used to scan the dominant leg (tibia)
and forearm (radius). Muscle cross-sectional area (CSA) was
estimated using a threshold below water equivalent linear
attenuation set at 0.22/cm. This threshold eliminated skin and
fat mass with lower linear attenuation in the cross-sectional slice.
From the remaining area, bone area was subtracted, revealing the
muscle at its maximum CSA.
Biochemical determinations
Venous blood samples were obtained between 08:00 and 10:00
AM after overnight fasting. All serum samples were stored at
280uC until batch analysis. Serum total testosterone (TT) and
estradiol (E2) levels were determined by liquid chromatography
tandem mass spectrometry (LC-MS/MS) (AB Sciex 5500 triple-
quadrupole mass spectrometer; AB Sciex, Toronto, Canada).
Serum limit of quantification was ,0.5 pg/mL (1.9 pmol/L) for
E2 and 1.2 ng/dL for T. The interassay coefficients of variation
(CV) were 4.0% at 21 pg/mL (77 pmol/L) for E2, and 8.3% at
36.7 ng/dL and 3.1% at 307.8 ng/dL for T [19]. Commercial
radioimmunoassays were used to determine serum levels of sex
hormone binding globulin (SHBG) (Orion Diagnostica, Espoo,
Finland), luteinizing hormone (LH) and follicle-stimulating hor-
mone (FSH) (ECLIA; Roche Diagnostics, Mannheim, Germany).
Free testosterone (FT) and free estradiol (FE2) concentrations were
calculated from serum TT, E2, SHBG and albumin concentrations
using a previously validated equation derived from the mass action
law [20,21].
Genotyping of the androgen receptor
Genomic DNA was extracted from EDTA-treated blood using a
commercial kit (Puregene kit; Gentra Systems, Minneapolis, MN,
USA). The CAG and GGN repeats were determined as previously
described [13].
Genotyping data for the AR gene for the Caucasian CEPH
population was downloaded from the International Haplotype
Mapping Project web site (http://www.hapmap.org) and the data
was incorporated into the Haploview program [22]. The tagger
function within Haploview was used to assign Tag SNPs. The
tagging SNPs were chosen, by aggressive tagging (use 2- or
3-marker haplotypes), to capture the variations within the gene
and the surrounding area with minor allele frequency (MAF) 0.01
and a minimum r2 of 0.80 (for their location and the SNPs which
they tag). For the SNP analyses, SNPlex [23] was carried out on
fragmented gDNA at a final concentration of 25 ng/ml (total
volume of 9 ml). Samples were run on an ABI 3730xl DNA
Analyzer (Applied Biosystems, Foster City, CA, USA) and data
were analysed using Gene Mapper v. 3.7 software (Applied
Biosystems). Genotype analysis was performed based on the
SNPlex_Rules_3730 method following the factory default rules.
Missing genotypes in the SNPlex analysis were obtained using
TagMan Pre-Designed SNP Genotyping AssaysH (Applied Bio-
systems) which were run on the StepOne System (Applied
Biosystems). In total, 5 SNPs of the AR gene were genotyped.
Statistics
Descriptives are expressed as mean 6 standard deviation or
median [1st–3rd quartile] when criteria for normality were not
fulfilled (Kolmogorov-Smirnov) and variables were log-trans-
formed in subsequent linear models. Linear mixed-effects model-
ling with random intercepts and a simple residual correlation
Androgens and Muscle Mass in Young Men
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structure was used to study the effect of anthropometrics, sex
steroid concentrations and genetic variations in the AR on muscle
mass and function, with adjustment for the confounding effect of
age, adult height and weight or fat mass and taking into account
the interdependence of measurements between brothers. Param-
eters of fixed effects were estimated via restricted maximum
likelihood estimation and reported as estimates of effect size (b)
with their respective standard error. A sample size of 677 subjects
allowed us a 81% power to detect a minimum effect size of 0.01 at
a two-sided significance level of 5%. Validity of the models was
assessed by exploring normality of distribution of the residuals.
SNPs were considered as a categorical variable, whereas CAG and
GGN lengths were analysed as continuous variables for assessing
association, and as categorical variable (quartiles) with groups
compared by one-way analysis of variance (ANOVA). Associations
were considered significant at p-values less than 0.05. Statistical
analyses were performed using S-Plus 7.0 (Insightful, Seattle, WA,
USA). The polygenic program in SOLAR 2.0 (Southwest
Foundation for Biomedical Research, San Antonio, TX, USA)
was used to estimate heritability, using a variance component
model.
Results
Study population and characteristics
Six hundred seventy seven subjects with a mean age of
34.565.5 years are included in the study. Mean height is
1.7960.06 m and mean weight 81.4611.8 kg, with a body mass
index of 25.363.5 kg/m2. Body composition and muscle function
parameters are given in Table 1.
As expected, the level of physical activity was associated with
muscle mass. Biceps force was positively associated with the level
of physical activity during work (b : 0.1860.03; p,0.0001) but not
related to physical activity during sports (p = 0.96), whereas
quadriceps force was related to sports (b : 0.1160.04; p = 0.004)
and not to physical activity during work (p = 0.52), independent
from age, height and weight.
Age, weight and height in relation to muscle mass and
force
Both fat (b : 0.260.05 kg/y; p = 0.0001) and lean mass (b :
0.160.05 kg/y; p = 0.03) increased with age, as well as muscle
CSA at the radius (b : 21 mm2/y64; p,0.0001) and tibia (b :
32 mm2/y68; p = 0.0001), which remained positive after addi-
tional adjustment for height, physical activity level and body fat
(radius: p,0.0001 and tibia: p = 0.004). With increasing age, lower
limb muscle force indices slightly decreased after adjustment for
height and weight (p = 0.02). Biceps muscle force and maximal
grip strength were unrelated to age.
Whole body lean mass was positively associated with height (b :
0.2260.02; p,0.0001) and weight (b : 0.7860.02; p,0.0001).
Also a close relationship between muscle CSA and weight (b :
0.5460.03; p,0.0001 for radius, and b : 0.5660.03; p,0.0001
for tibia) was found. Moreover, maximal grip strength and muscle
force indices at upper (biceps) and lower limb (quadriceps) were all
positively related to height (all p,0.0001) and weight (all
p,0.001).
Whole body lean mass exhibited a strong positive association
with muscle CSA and muscle function (all p,0.0001), whereas
whole body fat mass was inversely related to muscle CSA at radius
(p,0.0001) and grip strength and muscle force of biceps
(p,0.001).
The relationship of muscle CSA and muscle force (grip, biceps
and quadriceps) with height and weight are represented in
Figure 1.
Heritability of muscle mass and function
Table 2 illustrates the heritabilities of muscle mass and function
parameters. All parameters are highly heritable (p,0.0001), with
the highest h2 observed for whole body lean mass.
Muscle mass and force in relation to anthropometric
measurements
Whole body lean mass and muscle CSA at the radius were
positively associated with arm span (b : 0.2960.05; p,0.0001 and
b : 0.3160.07; p,0.0001 respectively) as well as with finger
(p = 0.0001 to 0.04) and hand length (all p,0.0001) adjusted for
height, weight and age. Fat mass was negatively associated with
arm span (b : 20.2360.03; p,0.0001). Moreover, biceps flexion
and hand grip force were related to arm span (b : 0.4660.06;
p,0.0001 for biceps and b : 0.4860.07; p,0.0001 for grip), even
more strongly than to hand length (b : 0.32 to 0.3460.05;
p,0.0001 for biceps and b : 0.3360.05; p,0.0001 for grip) and
finger length (b : 0.19 to 0.2460.04 ; p,0.0001 for biceps and b :
0.25 to 0.3060.04; p,0.0001 for grip). Muscle force and muscle
CSA were unrelated to sternum height (data not shown). All
Table 1. General characteristics and hormone concentrations
of all study participants (n = 677).
Mean ± SD
Age (yr) 34.565.5
Weight (kg) 81.4611.8
Height (m) 1.7960.06
BMI (kg/m2) 25.363.5
Testosterone (ng/dL) 579 [467.0–703.8]
Free testosterone (ng/dL) 14.2 [11.9–17.0]
Estradiol (ng/dL) 2.12 [1.67–2.57]
Free estradiol (ng/dL) 0.04 [0.03–0.05]
SHBG (nmol/L) 23 [18.4–29.7]
LH (U/L) 4.3 [3.1–5.5]
FSH (U/L) 3.8 [2.7–5.4]
Whole body lean mass (kg) 62.266.6
Whole body fat mass (kg) 16.466.4
Radius 66% muscle area (cm2) 45.265.9
Tibia 66% muscle area (cm2) 82.6611.1
Grip strength (kg) 51.768.0
Biceps force (Nm) 57.3610.5
Quadriceps force (Nm) 203642
Arm span (cm) 182.767.3
Hand length (cm) 20.561.0
Digit 2 finger length (cm) 7.460.5
Digit 4 finger length (cm) 7.660.5
Sternum height (cm) 61.562.7
Non-Gaussian distribution: data presented as median [1st–3rd quartile]. Free
testosterone and free estradiol serum concentrations were calculated using
previously validated equations [20,21].
doi:10.1371/journal.pone.0086235.t001
Androgens and Muscle Mass in Young Men
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e86235
associations remained positive after additional adjustment for fat
or lean mass.
Sex steroids in relation to muscle mass and function
TT and FT concentrations were positively related to whole
body lean mass (b : 0.0760.02; p = 0.0002 and b : 0.0860.02;
p,0.0001 respectively) and inversely to fat mass (b : 20.0760.02;
p = 0.0001 and b : 20.0860.02; p,0.0001 respectively), adjusted
for age, weight and height. TT concentrations were positively
related to muscle CSA at the tibia (b : 0.0760.04; p = 0.04), and
FT was positively associated with muscle CSA at the radius (b :
0.0760.04; p = 0.03). E2 and FE2 concentrations were negatively
associated with maximal grip strength (b : 20.0860.04; p = 0.04
and b : 20.1060.04; p = 0.007 respectively) and quadriceps force
Figure 1. Muscle CSA and muscle force (grip, biceps and quadriceps) according to quartiles of height and weight. P-values result from
ANOVA (overall difference between categories). Each bar represents the mean 6 standard deviation (SD).
doi:10.1371/journal.pone.0086235.g001
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(b : 20.0860.04; p = 0.02 and b : 20.1160.04; p = 0.002
respectively), even after additional adjustment for T. No influence
of TT or FT on muscle force was observed (data not shown). The
2D:4D finger length ratio and arm span were unrelated to
circulating steroid concentrations (data not shown).
Genetic variation in AR in relation to circulating sex
steroids, anthropometrics and muscle mass and function
The influence of genetic variation in the AR on circulating
gonadal steroids, body composition and muscle function is shown
in Table 3. The CAG repeat demonstrated a positive association
with circulating TT and FT concentration, as well as with E2 and
FE2 concentrations. Weak associations were found for the
rs5965433 and rs5919392 polymorphisms in the AR. However,
only the association between CAG repeat and TT and FT
remained significant after Bonferroni correction. No associations
between GGN repeat polymorphism and TT or FT concentra-
tions, as determined by LC-MS/MS, were found.
No consistent effects of the AR polymorphisms or CAG/GGN
repeats were found on either body composition, muscle mass or
muscle force (Table 3). Figure 2 illustrates the influence of the
CAG repeat polymorphism on anthropometrics. Arm span was
inversely associated with the number of CAG repeats (b :
20.0960.02; p = 0.0001). Adult height (Figure 2), hand and digit
4 length (data not shown) were unrelated to CAG length, but digit
2 length at both left and right hand was inversely related to the
CAG polymorphism (right b :20.0460.01; p = 0.0002 and left b :
20.0460.01; p = 0.002 adjusted for age and height). From the 7
genetic variations analysed, only the CAG repeat length was found
to be negatively related to the 2D:4D finger length ratio (right b :
20.0560.01; p = 0.0006 and left b: 20.0360.01; p = 0.01).
Discussion
In this cross-sectional study we investigated the interrelation
between androgen sensitivity, heritability, circulating sex steroids,
anthropometrics and muscle mass and function in a cohort of
young men. We observed that the number of CAG repeats is
associated with TT, FT, E2 and FE2 levels, and the 2D:4D finger
length ratio and arm span. In contrast with the observed
associations with circulating sex steroids, these genetic variations
in the AR did not influence muscle mass or function in this cohort
of young healthy men.
Our results are in agreement with twin studies reporting that
muscle mass and strength are highly heritable [1]. Some of the
remaining variance in muscle mass might be explained by
antropometry, which is also under genetic control [2–4]. Height
and weight were closely related to lean mass in our study. As taller
subjects have longer bones, it is reasonable that they have longer
muscles and thus higher muscle mass. Biceps force and hand grip
force were also found to be related with anthropometric
measurements, demonstrating that the strength of an individual
is strongly determined by its body size.
Age has also an influence on skeletal muscle mass and function
[3]. However, few studies have examined the relationship between
age and lean mass in (young) adults [24,25]. In our study, we
found a small but positive association between lean mass, muscle
CSA and age. The association of age with grip and biceps force,
and the small inverse relationship with quadriceps force supports
the results of Janssen et al. [25] which state that the muscle strength
of the upper body is preserved better with increasing age than the
muscle strength of the lower body.
The alterations in body composition with aging are thought to
be related to changes in sex steroid levels [26]. A loss of lean mass
and an increase in fat mass are observed in elderly and
hypogonadal men, whereas puberty in boys is associated with a
remarkable gain in muscle mass [3,5]. However, the clinical
relationship between androgens and muscle mass for variations
within the normal range is less clear. In this cohort of eugonadal
men, we demonstrated that whole body lean mass and muscle
CSA are positively associated with both TT and FT. It is
noteworthy that physical activity was also positively associated
with serum T concentrations, indicating a higher impact of
physical activity on muscle mass in men with higher serum T
levels. However, and in agreement with Folland et al. [8], further
analysis revealed that neither TT nor FT had any relation with
muscle strength.
As mentioned earlier, between-subject differences in serum T
levels within the physiological range are related in part to
differences in androgen sensitivity and hypothalamus-pituitary
feedback setpoint [9]. Genetic variations in the AR gene, in
particulary CAG repeat polymorphisms, have been associated
with disorders linked to a reduced androgen activity [27]. We have
previously shown that serum T levels are positively associated with
the CAG and GGN repeat length in young, middle-aged and
elderly men [9,13]. This is in contrast with the present study, in
which we did not find any correlation between TT or FT and the
GGN repeat length. It is noteworthy that the subjects of the
current study are partly overlapping (358 unrelated men i.e. a
single representative of the nuclear families out of 677 men) with
the cohort of young men published by Crabbe et al. [9] and
Bogaert et al. [13]. However, the serum concentrations of T have
been re-determined by a highly precise LC-MS/MS method, as
these were previously determined using less specific commercial
immunoassay kits. Reports on associations between the GGN
repeat and AR function are limited and inconsistent, with one
study describing a positive association in a cohort of men with
prostate cancer [28], whereas another study in young men could
not find an association between the GGN repeat and serum T
levels [29].
Based on studies reporting mutations in the AR gene related to
AIS [14–16] we further screened for genetic polymorphisms in the
AR that may affect the AR activity and thus circulating androgen
levels. Interestingly, two SNPs (rs5965433 and rs5919392) were
found to be significantly associated with FT, with the first also
borderline significantly associated with TT. However, it is
noteworthy that these associations did not remained significant
after Bonferroni correction. Two recent genome-wide association
studies [30,31] have identified several SNPs at different loci that
were associated with serum T levels in middle-aged and elderly
men. However, the AR gene was not described in these studies.
Considering our relatively limited sample size, we suggest that
Table 2. Heritability estimates of selected muscle parameters.
h2
Whole body lean mass (kg) 0.8660.09
Whole body fat mass (kg) 0.7360.10
Radius 66% muscle area (mm2) 0.6760.10
Tibia 66% muscle area (mm2) 0.6360.10
Grip strength (kg) 0.5660.10
Biceps force (Nm) 0.7660.10
Quadriceps force (Nm) 0.6760.10
doi:10.1371/journal.pone.0086235.t002
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analysis of our SNPs in those larger study populations may be
required to confirm our findings.
Genetic variation in the AR gene influences circulating
androgen levels, but may also affect body composition, muscular-
ity or anthropometrics. Data on the association between CAG
repeat length and muscle mass is limited and has been
contradictory [8,32,33]. In our study, we could not find any
relationship of CAG, GGN repeat length or the analysed SNPs in
the AR with either body composition or measurements of
muscularity. This might indicate that the relation of T with the
muscle CSA is not related to genetic factors influencing androgen
sensitivity, most likely because lower androgen sensitivity is
compensated by elevated T levels.
Interestingly, we found that arm span and the 2D:4D finger
length ratio were inversely associated with the number of CAG
repeats, but not with the GGN repeat lenght or the analysed SNPs.
The 2D:4D finger length ratio has been proposed as a marker of
prenatal androgen action and of sensitivity to T, with a lower
2D:4D being associated with high androgen exposure [34,35].
Given the hypothesis that elevated T levels in men with lower
androgen sensitivity do not necessary show differences in androgen
action, we can speculate that the negative effects on arm span and
Figure 2. Anthropometrics according to quartiles of AR CAG repeat polymorphism. P-values result from ANOVA (overall difference
between categories). Each bar represents the mean 6 standard deviation (SD).
doi:10.1371/journal.pone.0086235.g002
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finger length might be mediated by the higher levels of FE2 levels
found in men with longer CAG repeat length, as suggested by
Huhtamieni IT et al. [36]. As most E2 produced in normal men is
formed by aromatization of androgens [37], the higher T substrate
availability in men with lower androgen sensitivity can explain the
higher serum E2 levels. E2 is considered to be the main sex steroid
involved in the development and maintenance of bone mass [18].
In addition, it is also important to initiate epiphyseal closure of
long bones [38]. Therefore, we speculate that the presence of
higher levels of E2 in men with lower androgen sensitivity, but
preserved estrogen action, resulted in earlier termination of
longitudinal bone growth during puberty, an event wich is clearly
observed in boys with aromatase excess syndrome or familiar
hyperestrogenism [39,40].
To date, several studies have examined the possible relation of
adult sex hormone concentrations [41,42] and AR CAG number
[43–45] with 2D:4D, but results are controversial. To our
knowledge, there is only one study that has examined the
relationship between GGN repeat variation in the AR and
2D:4D ratios [46], but no reports on the relationship between
SNPs in AR and 2D:4D ratios exist.
The higher serum E2 levels found in men with a higher CAG
repeat number might also play a direct role on muscle force since
the negative association between E2 and grip strength and biceps
force, and between FE2 and grip strength and biceps force in our
study persisted after adjustment for T. Also Auyeung et al. [47]
reported that E2 levels, though positively related to muscle mass,
were negatively related to muscle strength. However, it should be
noted that the participants of the latter study were much older,
with lower T levels.
Possible effects of E2 on the regulation of muscle mass and
function are still poorly understood. As skeletal muscle myoblasts
and mature fibers express functional estrogen receptors (ER), a
direct effect of E2 in muscle cells may occur [48,49]. Although
some studies have shown that E2 is involved in muscle recovery
[50,51] and has anabolic effects [52,53], a negative role of E2 on
the musculature has also been suggested by others. Several studies
observed a decrease in muscle mass and force after E2
administration of ovariectomized rats [54–57], and Brown M et
al. [50] found an increase in muscle mass and function in ER
knockout mice. However, the exact mechanism by which
estrogens regulate muscle mass still has to be elucidated.
We recognize that our study has some limitations. First, our
study may have been limited by the relatively small sample size, by
which small but significant associations might have been missed,
especially for the genetics analysis. Secondly, observations within
brothers are not completely independent from each other.
However, all analyses in this study were performed using linear
mixed-effects modelling with random intercepts to account for this
interdependence. Furthermore, the cross-sectional design of this
study does not allow us to draw conclusions on causality.
A major strength of this study is that we have used a highly
precise LC-MS/MS method to determine T and E2 serum
concentrations. Most other studies used direct immunoassays,
which are thought to have a reduced specificity at lower
concentrations, especially those for serum E2 [58,59], which could
explain some of the conflicting results reported. Also, our cohort of
healthy men in a well-defined age range may have strengthened
our results.
In summary, in this study we showed that age, physical activity,
body composition, sex steroid levels and anthropometrics are all
determinants of muscle mass and function in young men.
Although the number of CAG repeats were related to sex steriod
levels and anthropometrics, we have no evidence that variations in
the AR gene also contributes to the between subject variation in
muscle mass or muscle function in young healthy men.
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